Tag: NASDAQ:RIGL

The stock of Rigel Pharmaceuticals (RIGL) has gone down by -14.63% for the week, with a -23.36% drop in the past month and a -21.64%

Company’s 36-month beta value is 0.99.Analysts have differing opinions on the stock, with 2 analysts rating it as a “buy,” 1 as “overweight,” 0 as

In the past week, RIGL stock has gone down by -13.73%, with a monthly decline of -19.41% and a quarterly plunge of -21.47%. The volatility